Axilone finalizes €313.6 million term loan B at 98 OID

By Sara Rosenberg

New York, June 15 – Axilone (CCP Lux Holding Sarl) firmed the original issue discount on its €313.6 million term loan B due January 2028 at 98, the tight end of the 97 to 98 talk, according to a market source.

Pricing on the term loan remained at Euribor plus 475 basis points.

RBC Capital Markets is the left lead arranger on the deal and the administrative agent.

Allocations are expected on Friday morning, the source added.

Proceeds will be used to amend and extend an existing €313.6 million term loan B due 2025.

The company is also amending and extending its existing $44.6 million term loan B to 2028 from 2025, but the extended U.S. tranche was not launched to the broad market.

Trustar is the sponsor.

Axilone is a Paris-based packaging specialist for the cosmetics, fragrance and skin care segments.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.